1.
Olanzapine in the treatment of developmental stuttering: a double-blind, placebo-controlled trial
by Maguire, Gerald A
Annals of clinical psychiatry, 2004, Vol.16 (2), p.63-67
2.
Developmental stuttering and Parkinson’s disease: the effects of levodopa treatment
by Anderson, Jeffrey M
Journal of neurology, neurosurgery and psychiatry, 1999, Vol.66 (6), p.776-778
3.
Management of Child and Adolescent Stuttering with Olanzapine: Three Case Reports
by Lavid, Nathan
Annals of clinical psychiatry, 1999, Vol.11 (4), p.233-236
4.
Stuttering: Neuropsychiatric features measured by content analysis of speech and the effect of risperidone on stuttering severity
by Maguire, Gerald A
Comprehensive psychiatry, 1999, Vol.40 (4), p.308-314
5.
Severe psychiatric symptoms associated with paroxetine withdrawal
by Bloch, Miki
The Lancet (British edition), 1995, Vol.346 (8966), p.57-57
6.
Activity of Intrinsic Laryngeal Muscles in Fluent and Disfluent Speech
by Smith, Anne
Journal of speech and hearing research, 1996, Vol.39 (2), p.329-348
7.
Fluency Changes in Persons Who Stutter Following a Double Blind Trial of Clomipramine and Desipramine
by Stager, Sheila V
Journal of speech and hearing research, 1995, Vol.38 (3), p.516-525
8.
Betaxolol and stuttering
by Burris, JamesF
The Lancet (British edition), 1990, Vol.335 (8683), p.223-223
9.
Bethanecol chloride in treatment of stuttering
by Hays, P
The Lancet (British edition), 1987, Vol.1 (8527), p.271-271
10.
Sulphinpyrazone in acute stuttering hemiparesis
by Lowe, G
British Medical Journal, 1977, Vol.2 (6079), p.125-125
11.
Haloperidol as a treatment for adult stuttering
by Swift, W.J
Comprehensive psychiatry, 1975, Vol.16 (1), p.61-67
12.
Letter: Possible remedy for stuttering
by Healy, C E
Pediatrics (Evanston), 1974, Vol.53 (4), p.587-588
13.
Haldol in the treatment of children with tics and stutterers--and an incidental finding
by Tapia, F
Psychiatric quarterly, 1969, Vol.43 (4), p.647-649
15.
Principal and differential effects of haoperidol and placebo treatments upon speech disfuluencies in stutterers
by Prins, D
Journal of speech and hearing research, 1980, Vol.23 (3), p.614-629
16.
Stuttering—The Effect of Treatment with D-Amphetamine and a Tranquilizing Agent, Trifluoperazine; A Preliminary Report on an Uncontrolled Study
by Fish, Charles H.
California medicine, 1965, Vol.103 (5), p.337-339
17.
An evaluation of the pharmacologic approaches to learning impediments
by Weiss, Charles F.
Pediatrics (Evanston), 1970, Vol.46 (1), p.142-144
18.
Periodic Fever and Hyperimmunoglobulin D Syndrome in a Boy with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Group A β-Hemolytic Streptococcus
by Ray, Perihan Cam
Journal of child and adolescent psychopharmacology, 2013, Vol.23 (4), p.32-304
19.
Drug-induced speech dysfluency and myoclonus preceding generalized tonic-clonic seizures in an adolescent male with schizophrenia
by Horga, Guillermo
Journal of child and adolescent psychopharmacology, 2010, Vol.20 (3), p.233-234
20.
Hashimoto's encephalopathy
by CHEN, H. C
Southern medical journal (Birmingham), 2000, Vol.93 (5), p.504-506
